HuGE Literature Finder
Records
1
-
1
Buparlisib in combination with tamoxifen in pretreated patients with hormone receptor-positive, HER2-negative advanced breast cancer molecularly stratified for PIK3CA mutations and loss of PTEN expression. Cancer medicine 2020 Apr . Welt Anja, Wiesweg Marcel, Theurer Sarah, Abenhardt Wolfgang, Groschek Matthias, Müller Lothar, Schröder Jan, Tewes Mitra, Chiabudini Marco, Potthoff Karin, Bankfalvi Agnes, Marschner Norbert, Schuler Martin, Breitenbücher Fra |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 29, 2023
- Content source: